Mark Pandori

4.9k total citations · 1 hit paper
83 papers, 3.3k citations indexed

About

Mark Pandori is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Mark Pandori has authored 83 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 24 papers in Epidemiology and 21 papers in Virology. Recurrent topics in Mark Pandori's work include Reproductive tract infections research (21 papers), HIV Research and Treatment (21 papers) and Syphilis Diagnosis and Treatment (13 papers). Mark Pandori is often cited by papers focused on Reproductive tract infections research (21 papers), HIV Research and Treatment (21 papers) and Syphilis Diagnosis and Treatment (13 papers). Mark Pandori collaborates with scholars based in United States, United Kingdom and Germany. Mark Pandori's co-authors include Heather M. Craig, John Guatelli, Jeffrey D. Klausner, Sally Liska, Andrew Gorzalski, Subhash C. Verma, Celsa A. Spina, Richard Tillett, Paul D. Hartley and Joel Sevinsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Mark Pandori

82 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic evidence for reinfection with SARS-CoV-2: a case study

2020 484 citations Joel Sevinsky, Andrew Gorzalski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Pandori United States	31	1.8k	1.0k	964	466	461	83	3.3k
Charles B. Hicks United States	36	2.3k 1.3×	2.1k 2.0×	886 0.9×	268 0.6×	341 0.7×	115	3.8k
Eric Sandström Sweden	35	1.6k 0.9×	1.7k 1.6×	1.2k 1.2×	743 1.6×	612 1.3×	169	3.9k
James W. Bremer United States	29	1.3k 0.7×	1.2k 1.2×	823 0.9×	338 0.7×	297 0.6×	71	2.5k
Katrien Fransen Belgium	32	2.4k 1.4×	2.3k 2.2×	1.0k 1.1×	312 0.7×	311 0.7×	118	3.3k
Kelly S. MacDonald Canada	34	1.5k 0.8×	2.3k 2.2×	1.4k 1.5×	783 1.7×	474 1.0×	94	4.3k
Joshua T. Schiffer United States	36	1.3k 0.8×	746 0.7×	1.9k 2.0×	245 0.5×	489 1.1×	133	3.6k
Leonard Maboko Germany	28	1.5k 0.8×	799 0.8×	948 1.0×	183 0.4×	210 0.5×	71	2.5k
T. Blake Ball Canada	33	949 0.5×	1.6k 1.6×	793 0.8×	654 1.4×	600 1.3×	107	3.2k
Katharine J Looker United Kingdom	20	660 0.4×	395 0.4×	2.3k 2.4×	510 1.1×	243 0.5×	39	3.2k
Miguel E. Quiñones‐Mateu United States	34	2.4k 1.3×	2.5k 2.4×	784 0.8×	382 0.8×	707 1.5×	110	3.7k

Countries citing papers authored by Mark Pandori

Since Specialization

Citations

This map shows the geographic impact of Mark Pandori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Pandori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Pandori more than expected).

Fields of papers citing papers by Mark Pandori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Pandori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Pandori. The network helps show where Mark Pandori may publish in the future.

Co-authorship network of co-authors of Mark Pandori

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Pandori. A scholar is included among the top collaborators of Mark Pandori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Pandori. Mark Pandori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ng, Justin H. J., Andrew Gorzalski, Adam Allred, et al.. (2024). The Next Frontier in Tuberculosis Investigation: Automated Whole Genome Sequencing for Mycobacterium tuberculosis Analysis. International Journal of Molecular Sciences. 25(14). 7909–7909. 4 indexed citations

Gorzalski, Andrew, Kevin Libuit, Vici Varghese, et al.. (2023). GAMBIT (Genomic Approximation Method for Bacterial Identification and Tracking): A methodology to rapidly leverage whole genome sequencing of bacterial isolates for clinical identification. PLoS ONE. 18(2). e0277575–e0277575. 13 indexed citations

Gorzalski, Andrew, et al.. (2023). Analysis of SARS-CoV-2 variants from patient specimens in Nevada from October 2020 to August 2021. Infection Genetics and Evolution. 111. 105434–105434. 1 indexed citations

Uppal, Timsy, et al.. (2022). Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay. SHILAP Revista de lepidopterología. 1(4). 100046–100046. 12 indexed citations

Gorzalski, Andrew, Subhash C. Verma, Joel Sevinsky, et al.. (2022). Rapid repeat infection of SARS-CoV-2 by two highly distinct delta-lineage viruses. Diagnostic Microbiology and Infectious Disease. 104(1). 115747–115747. 3 indexed citations

Levy, Vivian, et al.. (2016). A Case of Persistent and Possibly Treatment Resistant Pharyngeal Gonorrhea. Sexually Transmitted Diseases. 43(4). 258–259. 1 indexed citations

Buono, Sean, et al.. (2015). Fluoroquinolone Resistance in Neisseria gonorrhoeae After Cessation of Ciprofloxacin Usage in San Francisco. Sexually Transmitted Diseases. 42(2). 57–63. 12 indexed citations

Davis, J. Lucian, L. Masae Kawamura, Lelia H. Chaisson, et al.. (2014). Impact of GeneXpert MTB/RIF on Patients and Tuberculosis Programs in a Low-Burden Setting. A Hypothetical Trial. American Journal of Respiratory and Critical Care Medicine. 189(12). 1551–1559. 33 indexed citations

Hobohm, Dan, Lisa Hightow‐Weidman, Mark Pandori, et al.. (2013). Detection of Acute HIV Infection in Two Evaluations of a New HIV Diagnostic Testing Algorithm — United States, 2011–2013. Carolina Digital Repository (University of North Carolina at Chapel Hill). 31 indexed citations

10.

Getchell, Jane P., Kelly Wroblewski, Alfred DeMaria, et al.. (2013). Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians. MMWR Morbidity and Mortality Weekly Report. 62(18). 362–365. 232 indexed citations

11.

Wong, Ernest, et al.. (2011). Evaluation of an IgM/IgG Sensitive Enzyme Immunoassay and the Utility of Index Values for the Screening of Syphilis Infection in a High-Risk Population. Sexually Transmitted Diseases. 38(6). 528–532. 36 indexed citations

12.

Yukl, Steven A., Amandeep K. Shergill, Kenneth R. McQuaid, et al.. (2010). Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS. 24(16). 2451–2460. 188 indexed citations

13.

Klausner, Jeffrey D., Kyle T. Bernstein, Mark Pandori, et al.. (2009). Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations - five cities, United States, 2007.. MMWR Morbidity and Mortality Weekly Report. 58(26). 716–719. 37 indexed citations

14.

Pandori, Mark, et al.. (2006). Real-Time PCR for detection of herpes simplex virus without nucleic acid extraction. BMC Infectious Diseases. 6(1). 104–104. 19 indexed citations

15.

Pandori, Mark & Takeshi Sano. (2005). Chemically inactivated adenoviral vectors that can efficiently transduce target cells when delivered in the form of virus-microbead conjugates. Gene Therapy. 12(6). 521–533. 7 indexed citations

16.

Pandori, Mark, Jerzy Olejnik, Kenneth J. Rothschild, et al.. (2002). Photochemical Control of the Infectivity of Adenoviral Vectors Using a Novel Photocleavable Biotinylation Reagent. Chemistry & Biology. 9(5). 567–573. 16 indexed citations

17.

Pandori, Mark, et al.. (2002). Adenovirus–Microbead Conjugates Possess Enhanced Infectivity: A New Strategy for Localized Gene Delivery. Virology. 299(2). 204–212. 47 indexed citations

18.

Farlow, Samuel J., et al.. (2002). A chimera of a gelatinase inhibitor peptide with streptavidin as a bifunctional tumor targeting reagent. FEBS Letters. 516(1-3). 197–200. 4 indexed citations

19.

Craig, Heather M., Mark Pandori, Nanette L. Riggs, Douglas D. Richman, & John Guatelli. (1999). Analysis of the SH3-Binding Region of HIV-1 Nef: Partial Functional Defects Introduced by Mutations in the Polyproline Helix and the Hydrophobic Pocket. Virology. 262(1). 55–63. 27 indexed citations

20.

Riggs, Nanette L., Heather M. Craig, Mark Pandori, & John Guatelli. (1999). The Dileucine-Based Sorting Motif in HIV-1 Nef Is Not Required for Down-Regulation of Class I MHC. Virology. 258(2). 203–207. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact